NEPHROCARE HEALTH SERVICES LIMITED

Issue Date Price Band Bid Lot Registar BRLM
10 Dec, 2025 - 12 Dec, 2025 ₹ 438 - 460 32 shares & in multiples KFIN ICICI, AMBIT, IIFL, NOMURA

Subscription Level As On : 12-Dec-2025 11:59:04 PM

Category Book Size Subscription
No. of Shares Offered Amount No. of Shares Bid Amount No. of Times
@ Upper @ Upper
QIB 37,68,224 1,73,33,83,040 10,10,69,088 46,49,17,80,480 26.82
NII 28,27,843 1,30,08,07,780 7,00,52,352 32,22,40,81,920 24.77
NII (Above 10 lacs) 18,85,229 86,72,05,340 5,73,66,080 26,38,83,96,800 30.43
NII (2-10 lacs) 9,42,614 43,36,02,440 1,26,86,272 5,83,56,85,120 13.46
Retail 65,98,301 3,03,52,18,460 1,55,38,304 7,14,76,19,840 2.35
Employee 83,532 3,84,24,720 2,35,136 10,81,62,560 2.81
Total 1,32,77,900 6,10,78,34,000 18,68,94,880 85,97,16,44,800 14.08
www.ognajwala.in Applications : 3,34,670 (1.62)

Chirag Shah (Ognajwala)

Disclaimer: The above-mentioned information/data are sourced from the websites of the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on a real-time basis. For updated information/data, you can visit their respective website. The information/data provided herein above are for information purposes only and provided by Ognajwala.in on an "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Ognajwala.in does not guarantee or warrant the accuracy, adequacy, or completeness of the information received through the said websites. Ognajwala.in holds no responsibility of any kind as regards any discrepancies, errors, omissions, losses, or damages. Ognajwala.in including its affiliates and any of its officers, directors, personnel, and employees, shall not be liable for any loss, or damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information/data received through the said websites. The recipient alone shall be fully responsible/liable for any decision taken based on such information/data. All recipients should before acting upon the said information make their investigation, and seek appropriate professional advice.